Ultrasound imaging of carotid intima-media thickness: An office-based tool to assist physicians in cardiovascular risk assessment

Current Atherosclerosis Reports

Volumn 13, Issue 5, 2011, Pages 431-436

  Yang, Eric Y ^a   Nambi, Vijay ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

ARIC study; Atherosclerosis; Carotid IMT; Carotid intima media thickness; Carotid plaque; Carotid ultrasound; Framingham heart study; Risk assessment; Subclinical atherosclerosis

Indexed keywords

ATORVASTATIN; MEVINOLIN; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ARTERIAL WALL THICKNESS; ARTICLE; CARDIAC IMAGING; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY RISK; DISEASE ASSOCIATION; ECHOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FRAMINGHAM RISK SCORE; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR;

CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; HUMANS; IMAGING, THREE-DIMENSIONAL; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 81055156248     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-011-0200-5     Document Type: Article

References (42)

1. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-406. (Pubitemid 17189260)
2. Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound-determined intima-media thickness and atherosclerosis. Direct and indirect validation. Arterioscler Thromb. 1994;14:261-4.
3. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui MH, et al. Prevention conference v: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Noninvasive tests of atherosclerotic burden: Writing group iii. Circulation. 2000;101:E16-22.
4. Roman MJ, Naqvi TZ, Gardin JM, Gerhard-Herman M, Jaff M, Mohler E. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the american society of echocardiography and the society of vascular medicine and biology. J Am Soc Echocardiog. 2006;19:943-54. (Pubitemid 44118704)
5. Taylor AJ, Merz CN, Udelson JE. 34th bethesda conference: executive summary-can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? J Am Coll Cardiol. 2003;41:1860-2.
6. Nambi V, Chambless L, Folsom A, He M, Hu Y, Mosley T, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the aric (atherosclerosis risk in communities) study. J Am Coll Cardiol. 2010;55:1600-7.
7. Nambi V, Chambless L, He M, Folsom AR, Mosley T, Boerwinkle E, Ballantyne CM. Common carotid artery intimamedia thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the atherosclerosis risk in communities (aric) study. Eur Heart J. 2011
8. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the american society of echocardiography carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr. 2008;21:93-111. quiz 189-190. (Pubitemid 351193107)
9. Kanters SD, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke. 1997;28:665-71. (Pubitemid 27118395)
10. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the advisory board of the 3rd and 4th watching the risk symposium, 13th and 15th european stroke conferences, mannheim, germany, 2004, and brussels, belgium, 2006. Cerebrovasc Dis. 2007;23:75-80 (Pubitemid 46112808)
11. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by b-mode ultrasound. Aric investigators. Stroke. 1993;24:1297-304. (Pubitemid 23254630)
12. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson Jr SK, et al. Distribution and correlates of sonographically detected carotid artery disease in the cardiovascular health study. The chs collaborative research group. Stroke. 1992;23:1752-60.
13. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (the bogalusa heart study). Am J Cardiol. 2002;90:953-8. (Pubitemid 35232618)
14. D'Agostino Jr RB, Burke G, O'Leary D, Rewers M, Selby J, Savage PJ, et al. Ethnic differences in carotid wall thickness. The insulin resistance atherosclerosis study. Stroke. 1996;27:1744-9. (Pubitemid 26332497)
15. Lakka TA, Salonen R, Kaplan GA, Salonen JT. Blood pressure and the progression of carotid atherosclerosis in middle-aged men. Hypertension. 1999;34:51-6. (Pubitemid 29325718)
16. Diez-Roux AV, Nieto FJ, Comstock GW, Howard G, Szklo M. The relationship of active and passive smoking to carotid atherosclerosis 12-14 years later. Prev Med. 1995;24:48-55.
17. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, et al. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis risk in communities (aric) study investigators. Stroke. 1994;25:66-73.
18. Polak JF, Backlund JY, Cleary PA, Harrington AP, O'Leary DH, Lachin JM, et al. Progression of carotid artery intima-media thickness during 12 years in the diabetes control and complications trial/epidemiology of diabetes interventions and complications (dcct/edic) study. Diabetes. 2011;60:607-13.
19. Amarenco P, Labreuche J, Touboul PJ. High-density lipoproteincholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis. 2008;196:489-96. (Pubitemid 351146660)
20. Labreuche J, Touboul PJ, Amarenco P. Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies. Atherosclerosis. 2009;203:331-45.
21. Baldassarre D, Tremoli E, Franceschini G, Michelagnoli S, Sirtori CR. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke. 1996;27:1044-9. (Pubitemid 26177604)
22. Wallenfeldt K, Fagerberg B, Wikstrand J, Hulthe J. Oxidized lowdensity lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med. 2004;256:413-20. (Pubitemid 39434378)
23. Durga J, Verhoef P, Bots ML, Schouten E. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Atherosclerosis. 2004;176:1-19. (Pubitemid 39078639)
24. Kivimaki M, Lawlor DA, Juonala M, Smith GD, Elovainio M, Keltikangas-Jarvinen L, et al. Lifecourse socioeconomic position, c-reactive protein, and carotid intima-media thickness in young adults: The cardiovascular risk in young finns study. Arterioscler Thromb Vasc Biol. 2005;25:2197-202. (Pubitemid 41416321)
25. Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF, et al. Association of c-reactive protein with carotid atherosclerosis in men and women: the framingham heart study. Arterioscler Thromb Vasc Biol. 2002;22:1662-7.
26. Lorenz MW, Karbstein P, Markus HS, Sitzer M. High-sensitivity c-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke. 2007;38:1774-9. (Pubitemid 46847246)
27. Crouse 3rd JR, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW, et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries (plac-ii). Am J Cardiol. 1995;75:455-9.
28. Furberg CD, Adams Jr HP, Applegate WB, Byington RP, Espeland MA, Hartwell T, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic carotid artery progression study (acaps) research group. Circulation. 1994;90:1679-87. (Pubitemid 24320914)
29. Smilde TJ, van Wissen S, Wollersheim H, Trip MD, Kastelein JJ, Stalenhoef AF. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (asap): a prospective, randomised, double-blind trial. Lancet. 2001;357:577-81. (Pubitemid 32179609)
30. Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN. Arbiter: arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 2002;106:2055-60. (Pubitemid 35192810)
31. Crouse 3rd JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the meteor trial. JAMA. 2007;297:1344-53. (Pubitemid 46513235)
32. Espeland MA, O'Leary DH, Terry JG, Morgan T, Evans G, Mudra H. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of hmg-coa reductase inhibitors. Curr Control Trials Cardiovasc Med. 2005;6:3.
33. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intimamedia thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-67. (Pubitemid 46184197)
34. Pencina MJ, D'Agostino Sr RB, D'Agostino Jr RB, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the roc curve to reclassification and beyond. Stat Med. 2008;27:157-72. discussion 207-112. (Pubitemid 351193639)
35. Chambless LE, Folsom AR, Sharrett AR, Sorlie P, Couper D, Szklo M, et al. Coronary heart disease risk prediction in the atherosclerosis risk in communities (aric) study. J Clin Epidemiol. 2003;56:880-90. (Pubitemid 37162663)
36. Elias-Smale SE, Kavousi M, Verwoert GC, Koller MT, Steyerberg EW, Mattace-Raso FU, Hofman A, Hoeks AP, Reneman RS, Witteman JC. Common carotid intima-media thickness in cardiovascular risk stratification of older people: The rotterdam study. Eur J Cardiovasc Prev Rehabil. 2011
37. Lorenz MW, Schaefer C, Steinmetz H, Sitzer M. Is carotid intima media thickness useful for individual prediction of cardiovascular risk? Ten-year results from the carotid atherosclerosis progression study (caps). Eur Heart J. 2010;31:2041-8.
38. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 accf/aha guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation. 2010;122:e584-636.
39. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the american heart association. Circulation. 2011;123:1243-62.
40. Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation. 2002;106:3143-3421
41. Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel iii guidelines. J Am Coll Cardiol. 2004;44:720-32.
42. Appropriate use criteria for carotid intima media thickness testing. Atherosclerosis. 2011;214:43-46